Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A role for TNF-α in alveolar macrophage damage-associated molecular pattern release
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
View: Text | PDF
Research Article Immunology

A role for TNF-α in alveolar macrophage damage-associated molecular pattern release

  • Text
  • PDF
Abstract

Chronic beryllium disease (CBD) is a metal hypersensitivity/autoimmune disease in which damage-associated molecular patterns (DAMPs) promote a break in T cell tolerance and expansion of Be2+/self-peptide–reactive CD4+ T cells. In this study, we investigated the mechanism of cell death induced by beryllium particles in alveolar macrophages (AMs) and its impact on DAMP release. We found that phagocytosis of Be led to AM cell death independent of caspase, receptor-interacting protein kinases 1 and 3, or ROS activity. Before cell death, Be-exposed AMs secreted TNF-α that boosted intracellular stores of IL-1α followed by caspase-8–dependent fragmentation of DNA. IL-1α and nucleosomal DNA were subsequently released from AMs upon loss of plasma membrane integrity. In contrast, necrotic AMs released only unfragmented DNA and necroptotic AMs released only IL-1α. In mice exposed to Be, TNF-α promoted release of DAMPs and was required for the mobilization of immunogenic DCs, the expansion of Be-reactive CD4+ T cells, and pulmonary inflammation in a mouse model of CBD. Thus, early autocrine effects of particle-induced TNF-α on AMs led to a break in peripheral tolerance. This potentially novel mechanism may underlie the known relationship between fine particle inhalation, TNF-α, and loss of peripheral tolerance in T cell–mediated autoimmune disease and hypersensitivities.

Authors

Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee

×

Figure 2

AM cell death and DAMP release are regulated by separate pathways.

Options: View larger image (or click on image) Download as PowerPoint
AM cell death and DAMP release are regulated by separate pathways.
(A–C)...
(A–C) B6 AMs were pretreated with vehicle (Veh) or the indicated inhibitors for 15 minutes and then stimulated ± 50 μg/mL Be for 18 hours. AM necrosis and DAMP release were assessed as described in Figure 1. Percentage of AMs that were necrotic (left) and concentrations of DNA (middle) or IL-1α (right) in culture SNs are shown for each treatment group. (A) AMs were pretreated with Veh or 10 μM cytochalasin D (Cyto D). (B) AMs were pretreated with Veh or 20 μM Z-VAD-FMK (Z-VAD). (C) AMs were pretreated with Veh, 10 μM necrostatin-1 (NS), or 0.5 μM GSK′872 (GSK). Some samples were stimulated with 10 μg/mL LPS + 40 μM Z-VAD-FMK (LZ) as a positive control for necroptosis. (D) AMs were pretreated with vehicle (Veh), 20 μM Z-VAD-FMK (Z-VAD), 10 μM Z-FF-FMK, or Z-VAD + Z-FF-FMK. Concentrations of DNA in SNs are shown for each treatment group. (E) MH-S cells were pretreated with indicated concentrations of chloroquine (CQ) for 1 hour and then exposed to Be for 18 hours. The percentage of MH-S cells that underwent necrosis is shown. Data are combined from 3 independent experiments and performed in duplicate/experiment with separate cohorts of mice or passages of MH-S cells as a source of cells in each experiment. Symbols on graphs are mean values from each experiment ± SEM. A 1-way ANOVA was used to test for statistical differences between groups. Statistical P values for select comparisons are indicated as *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts